A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition

International Journal of Cancer

Volumn 121, Issue 8, 2007, Pages 1862-1868

  Casabonne, Delphine ^a   Michael, Kristina M ^b   Waterboer, Tim ^b   Pawlita, Michael ^b   Forslund, Ola ^c   Burk, Robert D ^d   Travis, Ruth C ^a   Key, Tim J ^a   Newton, Robert ^e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cutaneous squamous cell carcinoma (SCC); Epidemiology; Human papillomavirus (HPV); Prospective case control; Serology

Indexed keywords

CAPSID PROTEIN; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 34548677936     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22885     Document Type: Article

References (37)

1. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohm I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frdin L, Glattre E, Halvorsen S, et al. Cancer risk after renal transplantation in the nordic countries, 1964-1986. Int J Cancer 1995;60:183-9.
2. Adami J, Gbel H, Lindelöf B, Rydh B, Glimelius B, Ekbom A, Adami HO, Granath F. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003;89:1221-7.
3. Kinlen LJ, Sheil AGR, Peto J, Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. BMJ 1979;2:1461-6.
4. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans, Vol. 55: Solar and ultraviolet radiation. United States: Oxford University Press, 1992. 228 p.
5. Pfister H. Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003;31:52-6.
6. De Villiers E-M, Fauquet C, Broker TR, Bernard H-U, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17-27
7. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
8. Akgül B, Cooke JC, Storey A. HPV-associated skin disease. J Pathol 2006;208:165-75.
9. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000;74:11636-41.
10. Forslund O, Lindelöf B, Hradil E, Nordin P, Stenquist B, Kimbauer R, Slupetzty K, Dillner J. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "stripped" biopsies from the same tumors. J Invest Dermatol 2004;123:388-94.
11. Steger G, Olszewsky M, Stockfleth E, Pfister HJ. Prevalence of antibodies to human papillomavirus type 8 in human sera. J Virol 1990;64:4399-406.
12. Stark S, Petridis AK, Ghim S-J, Jenson AB, Bouwes Bavinck JN, Gross G, Stockfleth E, Fuchs PG, Pfister HJ. Prevalence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated hpv8 in patients at risk of skin cancer. J Invest Dermatol 1998;111:696-701.
13. Bouwes Bavinck JN, Stark S, Petridis AK, Marugg ME, Ter Schegget J, Westendorp RG, Fuchs PG, Vermeer BJ, Pfister HJ. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis associated human papillomavirus type 8 in patients with actinic keratoses. Br J Dermatol 2000;142:103-9.
14. Favre M, Majewski S, Noszczyk B, Maienfisch F, Pura A, Orth G, Jablonska S. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 2000;114:403-7.
15. Feltkamp MCW, Broer R, di Summa FM, Struijk L, Van der Meijden E, Verlaan BPJ, Westendorp RGJ, Ter Schegget J, Spaan WJM, Bouwes Bavinck JN. Seroactivity to epidermodysplasia verriciformis-related human papillomavirus type is associated with nonmelanoma skin cancer. Cancer Res 2003;63:2695-700.
16. Masini C, Fuchs PG, Gabrielli F, Stark S, Sera F, Ploner M, Melchi CM, Primavera G, Pirchio G, Picconi O, Petasecca P, Cattaruzza MS, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003;139:890-4.
17. Karagas RK, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green A, Bouwes Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinoma of the skin. J NCI 2006;98:389-95.
18. Struijk L, Hall L, Van der Meijden E, Wanningen P, Bouwes Bavinck JN, Neale R, Green AC, ter Schegget J, Feltkamp MCW. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidmiol Biomarkers Prev 2006;15:529-35.
19. Dang C, Koehler A, Forschner T, Sehr P, Michael K, Pawlita M, Stockfelth E, Nindl I. E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients. BJ D 2006;155:129-36.
20. Davey GK, Spencer EA, Appleby PN, Allen NE, Knox KH, Key TJ. EPIC-Oxford: lifestyle characteristics and nutrient intakes in a cohort of 33,883 meat-eaters and 31,546 non meat-eaters in the UK. Public Health Nutrition 2002;6:259-68.
21. Riboli E. Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol 1992;3:783-91.
22. Sehr P, Zumbach K, Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 2001;253:153-62.
23. Sehr P, Müller M, Höpfl R, Widschwendter A, Pawlita M. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods 2002;106:61-70.
24. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M. Multiplex Human Papillomavirus Serology based on in situ purified glutathione S-transferase fusion proteins. Clin Chem 2005;51:1845-53.
25. Waterboer T, Sehr P, Pawlita M. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 2006;309:200-4.
26. Forslund O, Ly H, Reid C, Higgins G. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003;149:64-73.
27. Chen Z, Schiffman M, Herrero R, DeSalle R, Burk RD. Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology 2007;360:447-53.
28. www.statistics.gov.uk
29. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000;74:11636-41.
30. Antonsson A, Karanfilovska S, Lindqvist PG, Hansson BG. General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol 2003;41:2509-14.
31. Shah KV, Viscidi RP, Alberg AJ, Helzlsouer KJ, Comstock GW. Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix. Cancer Epidemiol Biomarkers Prev 1997;6:233-7.
32. Chua KL, Wiklund F, Lenner P, Angstrom T, Hallmans G, Bergman F, Sapp M, Schiller J, Wadell G, Hjerpe A, Dillner J. A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears. Int J Cancer 1996;68:54-9.
33. Hisada M, van den Berg BJ, Strickler HD, Christianson RE, Wright WE, Waters DJ, Rabkin CS. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States). Cancer Causes Control 2001;12:335-41.
34. Newton R, Carpenter L, Casabonne D, Beral V, Babiker A, Darbyshire J, Weller I, Weiss R, Kwan A, Bourboulia D, Munoz F, Lagos D, et al. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1. Br J Cancer 2006;94:1504-9.
35. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981;2:1129-33.
36. Favre M, Orth G, Majewski S, Baloul S, Pura A, Jablonska S. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998;110:311-7.
37. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143:513-9.